Press Release

Press Release | Feb 26, 2019

The Private Equity Women Investor Network (PEWIN), the pre-eminent organization for senior-level women investment professionals in private equity, today announced that its Members – Adele Oliva (1315 Capital), Hollie Haynes (Luminate Capital Partners), Kristina Heinze (ParkerGale) and Kate Mitchell (Scale Venture Partners) – have each successfully closed a new fund.

Press Release | Feb 07, 2019

Onkos Surgical, Inc. announced today that it has launched MyTray, a fully integrated personal surgical planning solution that leverages preoperative imaging and the precision of surgeon specific procedural requirements; all delivered in the convenience of personalized instrumentation trays. The MyTray solution is powered by the company’s novel digital health platform called uDesign™.

Press Release | Feb 04, 2019

Colorescience®, leading dermatologist-recommended skincare and cosmetics company, is proud to introduce its latest innovation, the Colorescience Total Eye™ Restore Regimen, a comprehensive, 24-hour solution that immediately addresses multiple eye area concerns and provides long-term improvement.

Press Release | Jan 30, 2019

The announcement was made today, at the 15th annual Maui Derm Conference, that Impoyz Cream demonstrated efficacy early, with 14.2% of Impoyz patients achieving treatment success at day 8 versus 1.6% in the vehicle group. Treatment success was achieved when subjects received a “clear” or “almost clear” assessment, marking at least a 2-grade improvement from

Press Release | Jan 23, 2019

Biocoat, Inc. announced today that Steven Bell has joined the company as Chief Financial Officer (CFO). Based in Horsham, PA, Biocoat develops and licenses biomaterial coatings for interventional medical devices that are custom engineered to meet specific clinical design parameters.

Press Release | Jan 16, 2019

Biocoat, Inc., (Biocoat) a 27-year old privately held company, announced today that it has been acquired by 1315 Capital, a Philadelphia-based healthcare investment firm that provides expansion and growth capital to commercial-stage healthcare services, medical technology, and specialty pharmaceutical companies.

Press Release | Dec 10, 2018

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of the parent company of Genoptix, Inc. for $125 million in cash, as adjusted by working capital and other adjustments, and 1 million shares of NeoGenomics common stock. Genoptix is a leading clinical oncology laboratory,

Pages 1 2 3 4 5 6